23andMe CEO: I’ll sleep when we bring our full test back to market

Fast Company |
March 2016

In November 2013, the FDA publicly ordered 23andMe to cease sales. A few years later, 23andMe rebranded to offer only some health reports along with ancestry and genealogy reports, without the serious health indicators it initially had in mind. The company is working its way back to providing medical information.

Latest News From Genomes2People